All Stories

  1. A Pilot Study Evaluating Novel Urinary Biomarkers for Crohn’s Disease
  2. Impact of a Camp upon Disease-Specific Knowledge and Quality of Life in Children and Adolescents with Inflammatory Bowel Disease
  3. Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2)
  4. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
  5. Inflammatory Bowel Disease and the Intestinal Microbiota
  6. Thiopurine-induced pancreatitis in inflammatory bowel diseases
  7. Fecal Biomarkers in the Diagnosis and Monitoring of Crohnʼs Disease
  8. The Pathophysiology of Eosinophilic Esophagitis
  9. Sa1194 Prospective, Multicenter Capsule Endoscopy Study of Small Bowel Crohn's Disease Patients in Clinical Remission: Long-Term Follow-Up and Correlation With Faecal Lactoferrin and Calprotectin Levels
  10. Tu1240 Faecal M2-Pyruvate Kinase in Children With Cystic Fibrosis: Does Increased Cell Turnover From Childhood Explain the Increased Risk of Gastrointestinal Malignancy in Adulthood?
  11. Re: Nutritional risk screening and its clinical significance in hospitalized children
  12. Low rate of inflammatory bowel disease in the Australian indigenous paediatric population
  13. Development and Validation of a Pediatric IBD Knowledge Inventory Device
  14. IBD in Adolescents
  15. Fecal Biomarkers of Intestinal Health and Disease in Children
  16. Inflammatory Bowel Disease in Children of Middle Eastern Descent
  17. Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment
  18. Epidemiology and Natural History of IBD in the Paediatric Age
  19. Malnutrition screening tools need to be applied properly before they can be compared – Response to Letter to Editors by Gerasimidis et al.
  20. Are Thiopurines Always Contraindicated After Thiopurine‐Induced Pancreatitis in Inflammatory Bowel Disease?
  21. Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation
  22. Nutritional status and nutrition risk screening in hospitalized children in New Zealand
  23. Fecal Calprotectin Does Not Predict Endoscopic Remission in Inflammatory Bowel Disease
  24. Paediatric Growth Charts: How Do We Use Them and Can We Use Them Better?
  25. Exclusive enteral nutrition and induction of remission of active Crohn’s disease in children
  26. Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition
  27. S100A12: A noninvasive marker of inflammation in inflammatory bowel disease
  28. Pediatric Gastroenterology—challenges great and small
  29. A Review of the Use of Complementary and Alternative Medicines by Children with Inflammatory Bowel Disease
  30. Nutritional Management of Inflammatory Bowel Disease
  31. Assessment of nutritional status and nutritional risk in hospitalized Iranian children
  32. An update of the role of nutritional therapy in the management of Crohn’s disease
  33. The role of steroids in children with multiple recurrences of intussusception
  34. Use of Enteral Nutrition for the Control of Intestinal Inflammation in Pediatric Crohn Disease
  35. International survey of enteral nutrition protocols used in children with Crohn's disease
  36. Crohn’s and colitis in children and adolescents
  37. Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
  38. Paediatric growth charts: How do we use them and can we use them better?
  39. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model
  40. Update of fecal markers of inflammation in inflammatory bowel disease
  41. Respiratory disease and early serum S100A12 changes in very premature infants
  42. Complementary and alternative medicine in children attending gastroenterology clinics: Usage patterns and reasons for use
  43. Probiotic-mediated modulation of host inflammation
  44. Assessment of Nutritional Status and Serum Leptin in Children With Inflammatory Bowel Disease
  45. Osteoprotegerin in pediatric Crohnʼs disease and the effects of exclusive enteral nutrition
  46. Esophageal Subepithelial Fibrosis and Hyalinization Are Features of Eosinophilic Esophagitis
  47. Vitamin D Deficiency in Children with Inflammatory Bowel Disease
  48. Multiseptate Gallbladder in an Asymptomatic Child
  49. Physician Attitudes and Practices of Enteral Nutrition as Primary Treatment of Paediatric Crohn Disease in North America
  50. Host Attachment, Invasion, and Stimulation of Proinflammatory Cytokines by Campylobacter concisus and Other Non– Campylobacter jejuni Campylobacter Species
  51. Detection of Helicobacteraceae in Intestinal Biopsies of Children with Crohn’s Disease
  52. Subclinical Intestinal Inflammation in Siblings of Children with Crohn’s Disease
  53. Development and Assessment of a Modified Pediatric Crohn Disease Activity Index
  54. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohnʼs disease
  55. Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response
  56. Exclusive enteral nutrition in the management of perianal Crohn's disease in children
  57. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease
  58. Azathioprine and allopurinol: A two‐edged interaction
  59. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease
  60. C-Reactive Protein and Disease Activity in Children with Crohn’s Disease
  61. Management of cow's milk protein allergy in infants and young children: An expert panel perspective
  62. Exclusive enteral nutrition for children with Crohn's disease: Use in Australia and attitudes of Australian paediatric gastroenterologists
  63. T1745 A Prospective Multicenter Study of Outcomes and Predictors of Response in Severe Pediatric Ulcerative Colitis
  64. Dietary intakes of children with Crohn's disease
  65. Saccharomyces boulardii in a child with recurrent Clostridium difficile
  66. Defensins and inflammation: The role of defensins in inflammatory bowel disease
  67. Detection of Enterohepatic and Gastric Helicobacter Species in Fecal Specimens of Children with Crohn's Disease
  68. Eosinophilic esophagitis in children with celiac disease
  69. Anthropometric parameters and serum leptin levels in children with coeliac disease
  70. Combination of nutritional therapy and medical therapy for the management of enterovesical fistula in paediatric Crohn's disease: A case report
  71. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children
  72. Coeliac disease screening in children: assessment of a novel anti‐gliadin antibody assay
  73. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease
  74. Tapeworm infestation: a cause of iron deficiency anemia shown by capsule endoscopy
  75. Probiotics in paediatric gastrointestinal diseases
  76. Polymeric Formula Has Direct Anti-Inflammatory Effects on Enterocytes in an in VitroModel of Intestinal Inflammation
  77. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease
  78. Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach
  79. Fecal S100A12: A novel noninvasive marker in children with Crohnʼs disease
  80. S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease
  81. Avoiding Errors in the Identification and 16S rRNA Sequencing Data of Members of the Helicobacteriaceae Family Detected in Clinical Samples
  82. Nutrition and Nutritional Management of Crohns Disease in Children and Adolescents
  83. E9/324 – Serum S-100 proteins (A12 and calprotectin) are associated with bronchoalveolar lavage evidence of airway infection and inflammation in young children with cystic fibrosis and are potential simple non-invasive markers of early lung disease
  84. Probiotics and inflammatory bowel disease: a natural fit?
  85. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease
  86. A case of duodenal web occurring in Prader‐Willi syndrome
  87. Role of serum factors in epithelial cell responses to Helicobacter pylori infection in vitro
  88. Coeliac disease presenting as dermatitis herpetiformis in infancy
  89. Biliary colic: Is it gallstones?
  90. Helicobacter pylori Infection Induces Interleukin-18 Production in Gastric Epithelial (AGS) Cells
  91. Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro
  92. Helicobacter pylori and Peptic Ulcer: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition
  93. Is H. pylori Transmitted by young children with diarhoeal disease?
  94. Use of Formulae to Predict Esophageal Length in Children Undergoing pH Probe Studies
  95. Assay of Tracheal Pepsin as a Marker of Reflux Aspiration
  96. Fat Laden Macrophages in Tracheal Aspirates as a Marker of Reflux Aspiration: A Negative Report
  97. Accuracy of Office‐Based Immunoassays for the Diagnosis of Helicobacter pylori Infection in Children
  98. Oral tacrolimus treatment of severe colitis in children
  99. Helicobacter pylori Infection, Host Genes, and Disease Outcome
  100. Accuracy of office-based immunoassays for the diagnosis of Helicobacter pylori infection
  101. cagE Is a Virulence Factor Associated with Helicobacter pylori –Induced Duodenal Ulceration in Children
  102. Taming the RAGE of Inflammation
  103. FATAL ADENOVIRAL DISEASE IN SIBLINGS